Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sinziana Cristea"'
Publikováno v:
Children, Vol 11, Iss 7, p 885 (2024)
Background: Psoriasis and obesity are chronic, inflammatory diseases, sharing certain pathophysiological factors. Psoriasis, increasingly viewed as a systemic inflammatory condition, may have various symptoms beyond the skin manifestations. Methods:
Externí odkaz:
https://doaj.org/article/20c4675958e14ed984935f78487ff15d
Autor:
Nikunjkumar Patel, James F. Clarke, Farzaneh Salem, Tariq Abdulla, Frederico Martins, Sumit Arora, Eleftheria Tsakalozou, Arran Hodgkinson, Omid Arjmandi‐Tash, Sinziana Cristea, Priyanka Ghosh, Khondoker Alam, Sam G. Raney, Masoud Jamei, Sebastian Polak
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 8, Pp 1060-1084 (2022)
Abstract Physiologically‐based pharmacokinetic models combine knowledge about physiology, drug product properties, such as physicochemical parameters, absorption, distribution, metabolism, excretion characteristics, formulation attributes, and tria
Externí odkaz:
https://doaj.org/article/afd2ab177bf7434a8488d0d0e8d82e93
Autor:
Pieter De Cock, Peter De Paepe, Karel Allegaert, Annick de Jaeger, Elke H. J. Krekels, Sinziana Cristea, Catherijne A. J. Knibbe
Publikováno v:
The AAPS Journal
AAPS JOURNAL
AAPS Journal, 23(3):65. Springer New York
AAPS Journal, 23(3). SPRINGER
AAPS JOURNAL
AAPS Journal, 23(3):65. Springer New York
AAPS Journal, 23(3). SPRINGER
To date, information on the ontogeny of renal transporters is limited. Here, we propose to estimate the in vivo functional ontogeny of transporters using a combined population pharmacokinetic (popPK) and physiology-based pharmacokinetic (PBPK) modeli
Publikováno v:
Clinical Pharmacokinetics, 59(10), 1291-1301. Adis
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Introduction For drugs eliminated by glomerular filtration (GF), clearance (CL) is determined by GF rate (GFR) and the unbound fraction of the drug. When predicting CL of GF-eliminated drugs in children, instead of physiologically based pharmacokinet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68dc2357abce1e3e6ec1c202d8e46621
https://pure.eur.nl/en/publications/f0a8349c-f349-412d-a1c5-dc016e317d43
https://pure.eur.nl/en/publications/f0a8349c-f349-412d-a1c5-dc016e317d43
Autor:
Karel Allegaert, Sinziana Cristea, Elke H. J. Krekels, Amin Rostami-Hodjegan, Catherijne Knibbe
Publikováno v:
AAPS Journal, 22(4):87. Springer New York
The AAPS Journal
The AAPS Journal
Glomerular filtration (GF) and active tubular secretion (ATS) contribute to renal drug elimination, with the latter remaining understudied across the pediatric age range. Therefore, we systematically analyzed the influence of transporter ontogeny on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d19cc84e233fcd9562a988f0cbf6562b
https://pure.eur.nl/en/publications/58b9f5bc-5455-446b-b236-b7bc95debd7d
https://pure.eur.nl/en/publications/58b9f5bc-5455-446b-b236-b7bc95debd7d
Autor:
Sinziana Cristea, Karel Allegaert, Amílcar Falcão, Anne Smits, F. Falcao, Ranil de Silva, Catherijne A. J. Knibbe, Ehj Krekels
Publikováno v:
Antimicrobial Agents & Chemotherapy, 63(8):e00853-19. American Society for Microbiology
Antimicrobial Agents and Chemotherapy, 63(8), e00853
Antimicrobial Agents and Chemotherapy, 63(8), e00853
Ibuprofen and indomethacin are commonly used to induce ductus arteriosus closure in preterm neonates. Our group previously reported that ibuprofen decreased vancomycin clearance by 16%. In this study, we quantified the impact of indomethacin coadmini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::237d9b9135f8846db576107192a4425d
https://lirias.kuleuven.be/handle/123456789/638388
https://lirias.kuleuven.be/handle/123456789/638388
Autor:
Victor Mangas-Sanjuan, Sandra M. den Hoedt, Dirk-Jan van den Berg, Robin Hartman, Francisco Bellanti, Sinziana Cristea, Elizabeth C. M. de Lange, Jana K. Geuer, Shinji Shimizu
To understand the drivers in the biological system response to dopamine D2 receptor antagonists, a mechanistic semiphysiologically based (PB) pharmacokinetic-pharmacodymanic (PKPD) model was developed to describe prolactin responses to risperidone (R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fddbb4142da67d3fa94fb461d5e5b920
http://hdl.handle.net/1887/3201806
http://hdl.handle.net/1887/3201806
Autor:
Sinziana Cristea, Catherijne A. J. Knibbe, Anne Smits, Karel Allegaert, Mirjam M. van Weissenbruch, Aida Kulo, Elke H. J. Krekels
Publikováno v:
Antimicrobial Agents & Chemotherapy, 61(12):e01282-17. American Society for Microbiology
Cristea, S, Smits, A, Kulo, A, Knibbe, C A J, Van Weissenbruch, M, Krekels, E H J & Allegaert, K 2017, ' Amikacin pharmacokinetics to optimize dosing in neonates with perinatal asphyxia treated with hypothermia ', Antimicrobial Agents and Chemotherapy, vol. 61, no. 12, e01282 . https://doi.org/10.1128/AAC.01282-17
Antimicrobial Agents and Chemotherapy, 61(12):e01282. American Society for Microbiology
Cristea, S, Smits, A, Kulo, A, Knibbe, C A J, Van Weissenbruch, M, Krekels, E H J & Allegaert, K 2017, ' Amikacin pharmacokinetics to optimize dosing in neonates with perinatal asphyxia treated with hypothermia ', Antimicrobial Agents and Chemotherapy, vol. 61, no. 12, e01282 . https://doi.org/10.1128/AAC.01282-17
Antimicrobial Agents and Chemotherapy, 61(12):e01282. American Society for Microbiology
Aminoglycosides pharmacokinetics (PK) is expected to change in neonates with perinatal asphyxia treated with therapeutic hypothermia (PATH). Several amikacin dosing guidelines have been proposed to treat neonates with (suspected) septicemia, however,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bffb2557d59ec58bb08f56744de5846
https://pure.eur.nl/en/publications/122725f0-c9ef-4db1-909d-1333d1317090
https://pure.eur.nl/en/publications/122725f0-c9ef-4db1-909d-1333d1317090